Mobile Health Application Developed for Cervical Cancer

NCT ID: NCT05378542

Last Updated: 2022-05-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-22

Study Completion Date

2022-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main purpose of this research is to evaluate the effect of the nursing care that participants receive with the mobile health application for cervical cancer on raising awareness about cervical cancer. The study conducted through the mobile health application developed to raise awareness about cervical cancer; It is thought that it is important in terms of raising awareness of participants, easing the work-time burden of health personnel in this period, and reducing the cost of health care through early diagnosis and treatment, and will set an example for future studies. Positive outputs from the mobile application will allow the application to be used on national and international platforms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the face-to-face health care system, especially due to the pandemic period, the problem of personnel need to provide health care can be solved with mobile health applications; thus, mobile health applications can indirectly help workforce problems. Mobile applications allow the provision of high quality, useful services with less energy and cost to large audiences. In addition, mobile health applications allow patients to be followed remotely, allowing patients to access health services wherever, whenever and as often as they want. It is stated that well-structured mobile applications have a positive impact on the health sector. In this context, it is seen that the use of mobile applications in primary, secondary and tertiary healthcare services is becoming increasingly common all over the world.

In researches planned study, it is aimed to develop a mobile application in Turkish in order to raise awareness about cervical cancer and to evaluate its effectiveness. In the content of the mobile application to be developed, information about cervical cancer such as information about cervical cancer, symptoms, findings, diagnosis, screening, treatment, practical explanations with video, frequently asked questions about the subject; It is planned to have interim notifications, reminders, pay attention warning messages. There are a limited number of practices related to cervical cancer awareness in the world. In Turkey, there is no e-health mobile application for cervical cancer awareness. Unlike the applications in the world; In the application, which is aimed to be developed in this study, there is an area where the participants can ask questions to the researcher from the "Request Support" section and there is a field. The information provided by mobile health applications was found to be educational, appropriate, original and on-site, and it was found useful to be reliable. Studies have shown that mobile health applications contribute to positive health outcomes.

The study conducted through the mobile health application developed to raise awareness about cervical cancer; It is thought that it is important in terms of raising the awareness of participants, easing the work-time burden of health personnel in this period, and reducing the cost of health care through early diagnosis and treatment, and will set an example for future studies. Positive outputs from the mobile application will allow the application to be used on national and international platforms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The research is a single center, parallel group, stratified block randomized controlled experimental study.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Stratified block randomization will be used to avoid selection bias. In this study on application bias, researcher and participant blinding will not be done. Because the researcher will make the application himself and placebo cannot be used in the intervention.

Data collection forms to prevent detection bias will be applied online through Google Forms® independently of the researcher.

The data obtained from the research aimed at preventing reporting bias will be coded as A and B by an independent researcher and transferred to the SPSS program. Analysis of the data will also be done by an independent statistician.

In order to prevent attrition bias, Intention to Treat Test will be used in the sample group in case of missing/subtracting or not completing the post-tests.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1. group

participants will receive information about cervical cancer with the developed mobile application.

Group Type ACTIVE_COMPARATOR

Mobile application usage

Intervention Type BEHAVIORAL

The implementation of the research was carried out in two stages. In the first stage, a mobile application was created, in the second stage, training and counseling was given to the experimental group with the mobile application, and no attempt was made to the control group.

2. group

No Intervention: control group (non-education) Routıne care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile application usage

The implementation of the research was carried out in two stages. In the first stage, a mobile application was created, in the second stage, training and counseling was given to the experimental group with the mobile application, and no attempt was made to the control group.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being 18 and over
* Able to understand and speak Turkish
* ability to read and write
* Owning a smartphone

Exclusion Criteria

* Having a communication barrier (seeing, understanding...)
* Having been diagnosed with cervical cancer in himself or his first degree relatives
* Not wanting to leave work
* the lost of life,
* Not participating in the final tests,
* Failure to complete parts of the mobile application within the specified time,
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gazi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Şengül Yaman Sözbir

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

seçil güneysu tunaman

Role: PRINCIPAL_INVESTIGATOR

bursa provincial health directorate

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gazi University

Ankara, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

SEÇİL GÜNEYSU TUNAMAN

Role: CONTACT

05539751733

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Şengül Y Sözbir

Role: primary

03122162609

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

006scltnmn

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.